Myelodysplastic syndromes complicated by atypical Sweet syndrome: a brief research report
-
By
-
Bianhong Wang
-
Kun Qian
-
Hao Liu
-
Yuehua Huang
-
Yanying Wang
-
Lihong Li
-
Fan Yu
-
May 28, 2026
-
Clinical Scorecard: Atypical Sweet Syndrome in Patients with Myelodysplastic Syndromes: A Concise Research Overview
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | Paraneoplastic dermatosis linked to hematologic malignancies, particularly MDS. |
| Target Population | |
| Care Setting | |
Key Highlights
- Atypical SS is a significant paraneoplastic syndrome frequently associated with MDS, characterized by painful erythematous plaques.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
- Monitor for cutaneous manifestations, response to treatment, and overall hematologic status in patients with MDS.
Risks
Patient & Prescribing Data
Three patients diagnosed with MDS complicated by atypical SS.
Treatment included systemic glucocorticoids and MDS-targeted therapies.
Clinical Best Practices
- Conduct thorough evaluation for infectious etiologies in patients presenting with SS.
- Utilize histopathological examination to confirm diagnosis of atypical SS.
- Establish a follow-up care plan to monitor for recurrence of SS and manage MDS.
Related Resources & Content
